A NEW Online Rational Medicines Use Module will be offered by
the University of the Western Cape Schools of Public Health and
Pharmacy, in collaboration with the SIAPS, Prof Richard Laing (BUSPH and
ex-WHO) and other partners.
This 15-credit online masters-level module will run from July-November
2015 and may be taken as a single continuing education module or as an
elective in the existing MPH at UWC. (Attendance at one week RMU Winter
School short course 29 June-3 July 2015 recommended but not compulsory).
For information on module and application details see: _
http://www.uwc.ac.za/Faculties/CHS/soph/News/Pages/NEW-Online-Rational-Medicines-Use-Module.aspx_
Applications close: 7 June 2015
Further information from Dr Hazel Bradley:
hbradley@uwc.ac.za
+27 21 9592630/2809
This module is specifically developed to equip healthcare professionals
such as pharmacists, doctors and nurses with the necessary skills to
improve rational medicines use.It will be of value to members of
Pharmacy and Therapeutics Committees, MPH students and staff working in
pharmacy and health departments in South Africa and other African
countries. The module builds on the one-week Rational Medicines Use
Winter School short-course which will be held 29 June - 3 July 2015
(attendance recommended but not compulsory).
The 15-credit, online masters-level module (NQF9) may be taken as a
single continuing education accredited module or as an elective module
in the existing MPH programme at UWC. Additional online modules focusing
on Pharmaceutical Public Health will be available in 2016.
Module Content
- Rational medicines use and problems associated with irrational medicine use;
- Medicines use problems using several quantitative methods such as, prescribing indicator studies, application of defined daily dose (DDD) and ABC
- Qualitative methods to investigate prescribing behaviour and medicine use;
- Promotion of rational medicine use including educational, managerial, economic and regulatory interventions;
- Medicines Use Evaluation (MUE) and its application to programmes
- Essential Medicines Concept and the development of Standard Treatment Guidelines (STGs) and Essential Medicines Lists (EMLs) using evidence-based decision making principles;
- Infection Control and Antimicrobial Resistance (AMR) concepts with respect to global and local situations and multifaceted strategies required
- Pharmacy and Therapeutics Committees (PTCs) and stewardship of RMU;
- Development of a plan for a defined medicine use problem to quantify, investigate and intervene, with evaluation.
Method of Teaching and Assessment
Students will be provided with all materials in an electronic format over the web and by electronic storage
media. Key reading materials will be provided. There will be short weekly tasks, several web-based discussion forums and two written assignments. Official language: English
Admission requirements:
Honours-level degree (NQF8), or equivalent, in a relevant discipline.
Module Cost: R8 000 (South African citizens) and US$1,300 (Other)
[Note: RMU Short-course Winter School fees waived for registered RMU Online Module participants]
Friday, 22 May 2015
Tuesday, 19 May 2015
First Training Workshop and Symposium MURIA Group 27 - 29 July 2015 University of Botswana, Gaborone
The Medicines Utilisation Research in Africa (MURIA) Group (see
http://muria.nmmu.ac.za/)
is holding its first training and workshop
and symposium in Gaborone, Botswana on 27-29 July 2015. The flyer and
registration form can also be downloaded from
http://muria.nmmu.ac.za/
Please direct all queries regarding these scholarships - which are
restricted to medically-qualified applicants - to email:
Muria.Group@mopipi.ub.bw
Regards
Andy
~~
Criteria for sponsorship by IUPHAR to the Medicines Utilization Research in Africa (MURIA) workshop and symposium in Botswana 26-29 July 2015.
The MURIA workshop and symposium organizing committee reaches out to
clinical pharmacologists and MD/ MBBS doctors with a pharmacology
background in the African region who can make significant
contributions to learning and exchange of research ideas and be able
to actively participate in discussions on the rational use of
medicines in Africa in the English language. The MURIA organizing
committee also seeks to ensure a balanced gender representation among
potential participants.
The MURIA organizing committee has therefore identified four main
criteria for selecting IUPHAR candidates to award sponsorship for
attending and presenting at the MURIA workshop/symposium in July 2015.
These are:
1. Applicants must be MD/MBBS physicians from academia
(mainly from Universities) with a clinical pharmacology/ pharmacology
qualification
2. Alternatively, applicants can be representatives from
think tanks such as those from research institutions based in the
African region with an MD/MBBS qualification with a clinical
pharmacology/ pharmacology background
3. Applicants can also be critical thinkers from the
African region that generate policy-oriented research, analysis and
advice to inform medicine policy development with an MD/MBBS and
pharmacology/ clinical pharmacology qualification. Applicants can be
from Ministries of Health, medical AID schemes, and private medical
practitioners dealing with medicines use
4. IUPHAR sponsorship will only be given to those who
submit an abstract that is accepted by the organizing committee
(submission deadline end May 2015). Preference will be given to
applicants whose abstract has been selected for an oral presentation.
Please indicate in your abstract submission that you are eligible for
the IUPHAR sponsorship
(Abstract forms and details can be found on
http://muria.nmmu.ac.za/).
The successful applicant will be notified
by June 3 2015. The MURIA Group's decision will be final.
Additional information about the IUPHAR sponsorship:
Sponsorship will be limited to the following items:
• Return airfare (up to a maximum of US$500 – greater in
exceptional circumstances upon request up to a maximum of US$750 per
person).
• Registration fee (equivalent to US$125.00 – this will be
paid for by the MURIA group)
• Accommodation for 3 nights in the Oasis Hotel, Gaborone,
Botswana (this will be organised and paid for by the MURIA Group)
The cost of the airfare (up to US$500 or more in exceptional
circumstances) will be refunded after the MURIA meeting in July on
receipt of the invoice documenting the details (this can be given
together with bank details to the MURIA organisers in Botswana).
--
Andy Gray BPharm MSc(Pharm) FPS FFIP
Senior Lecturer
Division of Pharmacology
Discipline of Pharmaceutical Sciences
School of Health Sciences
Consultant Pharmacist (Research Associate)
Centre for the AIDS Programme of Research in South Africa (CAPRISA)
University of KwaZulu-Natal
PBag 7 Congella 4013
South Africa
Tel: +27-31-2604298 Fax: +27-31-2604338
email: graya1@ukzn.ac.za or andy@gray.za.net
http://muria.nmmu.ac.za/)
is holding its first training and workshop
and symposium in Gaborone, Botswana on 27-29 July 2015. The flyer and
registration form can also be downloaded from
http://muria.nmmu.ac.za/
Please direct all queries regarding these scholarships - which are
restricted to medically-qualified applicants - to email:
Muria.Group@mopipi.ub.bw
Regards
Andy
~~
Criteria for sponsorship by IUPHAR to the Medicines Utilization Research in Africa (MURIA) workshop and symposium in Botswana 26-29 July 2015.
The MURIA workshop and symposium organizing committee reaches out to
clinical pharmacologists and MD/ MBBS doctors with a pharmacology
background in the African region who can make significant
contributions to learning and exchange of research ideas and be able
to actively participate in discussions on the rational use of
medicines in Africa in the English language. The MURIA organizing
committee also seeks to ensure a balanced gender representation among
potential participants.
The MURIA organizing committee has therefore identified four main
criteria for selecting IUPHAR candidates to award sponsorship for
attending and presenting at the MURIA workshop/symposium in July 2015.
These are:
1. Applicants must be MD/MBBS physicians from academia
(mainly from Universities) with a clinical pharmacology/ pharmacology
qualification
2. Alternatively, applicants can be representatives from
think tanks such as those from research institutions based in the
African region with an MD/MBBS qualification with a clinical
pharmacology/ pharmacology background
3. Applicants can also be critical thinkers from the
African region that generate policy-oriented research, analysis and
advice to inform medicine policy development with an MD/MBBS and
pharmacology/ clinical pharmacology qualification. Applicants can be
from Ministries of Health, medical AID schemes, and private medical
practitioners dealing with medicines use
4. IUPHAR sponsorship will only be given to those who
submit an abstract that is accepted by the organizing committee
(submission deadline end May 2015). Preference will be given to
applicants whose abstract has been selected for an oral presentation.
Please indicate in your abstract submission that you are eligible for
the IUPHAR sponsorship
(Abstract forms and details can be found on
http://muria.nmmu.ac.za/).
The successful applicant will be notified
by June 3 2015. The MURIA Group's decision will be final.
Additional information about the IUPHAR sponsorship:
Sponsorship will be limited to the following items:
• Return airfare (up to a maximum of US$500 – greater in
exceptional circumstances upon request up to a maximum of US$750 per
person).
• Registration fee (equivalent to US$125.00 – this will be
paid for by the MURIA group)
• Accommodation for 3 nights in the Oasis Hotel, Gaborone,
Botswana (this will be organised and paid for by the MURIA Group)
The cost of the airfare (up to US$500 or more in exceptional
circumstances) will be refunded after the MURIA meeting in July on
receipt of the invoice documenting the details (this can be given
together with bank details to the MURIA organisers in Botswana).
--
Andy Gray BPharm MSc(Pharm) FPS FFIP
Senior Lecturer
Division of Pharmacology
Discipline of Pharmaceutical Sciences
School of Health Sciences
Consultant Pharmacist (Research Associate)
Centre for the AIDS Programme of Research in South Africa (CAPRISA)
University of KwaZulu-Natal
PBag 7 Congella 4013
South Africa
Tel: +27-31-2604298 Fax: +27-31-2604338
email: graya1@ukzn.ac.za or andy@gray.za.net
Tuesday, 12 May 2015
HOSPITALI YA TAIFA MUHIMBILI TAARIFA YA DHARURA KWA UMMA KUHUSU KUCHANGIA DAMU HOSPITALI YA TAIFA MUHIMBILI
Menejimenti ya Hospitali ya Taifa Muhimbili inawaomba Watanzania, mashirika ya umma, mashirika yasiyo ya kiserikali, mashule, taasisi za kidini, na vyuo mbalimbali kujitokeza kusaidia kuchangia damu Hospitalini hapa ili kuokoa maisha ya wagonjwa. Hospitali inahitaji chupa za damu kwa wastani wa chupa 70 hadi 100 kwa siku.
Matumizi ya Damu:
Damu inatumika sana kwa wagonjwa wa dharura, akina mama wajawazito, wagonjwa waliofanyiwa upasuaji, watoto pamoja na wagonjwa wa saratani.
Upasuaji wa Moyo:
Kila mgonjwa wa upasuaji wa moyo anahitaji kiasi cha chupa tano mpaka sita za damu. Matumizi haya yanafanyika kabla, wakati na baada ya kufanyiwa upasuaji.
Katika juma hili kuna kambi maalum za madaktari Bingwa wa Moyo kutoka nchi mbalimbali ambao wanashirikiana na madaktari wetu kufanya upasuaji wa moyo kati ya wagonjwa watano hadi sita kwa siku na kufanya wagonjwa wa moyo pekee kuhitaji chupa 30 hadi 36 kwa siku sawa na akiba ndogo ya damu tuliyo nayo kwa siku. Kambi hizi zimeanza mapema Aprili mwaka huu na tunatarajia kuwa nazo katika kipindi cha miezi mitatu ijayo. Ili madaktari hawa waendelee kuja na kufanya upasuaji wa moyo kwa ufanisi wanahitaji uwepo wa damu.
Vyanzo vya Damu kwa MNH
Hospitali inategemea kupata damu kutoka vyanzo vikuu viwili ambavyo ni ndani ya Hospitali na kutoka Mpango wa Taifa wa Damu Salama (NBTS).
Hali Halisi ya Upatikanaji Damu kwa Sasa:
Makusanyo ya damu kutoka vyanzo vya ndani ni kati ya chupa 20 hadi 40 kwa siku zinazoweza kutumika kwa wagonjwa.
Aidha, upatikanaji wa damu kutoka Mpango wa Taifa wa Damu Salama (NBTS) ambao kisheria ndiyo wenye mamlaka ya kukusanya damu na kusambaza nchini umekuwa wa kiwango cha chini na hata wakati mwingine tumeshindwa kupata damu kutoka NBTS. Mathalani kuanzia Aprili 17, 2015 hatukuweza kupata damu hata chupa moja kutoka NBTS hali iliyopelekea upungufu mkubwa wa damu Hospitalini hapa kulingana na mahitaji.
Hospitali imejipanga kupitia Kitengo chake cha Uchangiaji Damu kilichopo Maabara Kuu ya Hospitali ya Taifa Muhimbili kuwapokea watu watakaojitokeza kuchangia damu.
Imetolewa na;
Aminiel Aligaesha
Mkuu wa Kitengo cha Mawasiliano ya Umma na Huduma kwa Wateja
Hospitali ya Taifa Muhimbili
Mei 11, 2015
Quality Assurance in Supply Chain Management of Medicines 1 June- 29 June, 450 euros
Dear all, we are pleased to announce that registration is open for the following courses.
Please find detailed course programmes and registration instructions on
www.iplusacademy.org .
- Quality Assurance in Supply Chain Management of Medicines
1 June- 29 June, 450 euros,
http://www.iplusacademy.org/enrol/iplus/cmp.php?courseid=66
Ensuring the quality of medicines is a major public health concern.
The emergence of substandard and counterfeit medicines, coupled with inefficient supply chain systems, not only poses a risk of negative health outcomes but also leads to economic losses and lack of trust in the health system.
To address these issues and develop evidence-based strategies,
it is important that people at all levels, from policy makers to primary healthcare workers appreciate
and comprehend the need for effective QA systems.
This course will introduce you to the concepts and main principles of quality assurance,
and will develop further skills and knowledge in different aspects of quality assurance
such as pharmaceutical regulation, pharmacovigilance and quality control of medicines.
After having successfully completed the module, students will be able to:
Define the key concepts and principles of quality assurance.
Comprehend the importance of quality assurance systems for medicines.
Describe how different functions of supply chain management affect the quality of medicines.
Explain the significance of shelf life and differentiate between types of stability studies.
Underline the key issues and challenges surrounding quality assurance systems especially in low and middle income countries.
- Basic principles of SCM in for health systems ( MBA level)
15 June-27 July, 450 euros,
http://www.iplusacademy.org/course/view.php?id=69
Many of the issues of healthcare quality and safety are consequences of poor management of pharmaceuticals.
Globally it is estimated that an average 25% of the total health expenditure is on medicines,
with poorer countries spending as much as 30%.
Knowledge of the full supply chain cycle of pharmaceuticals and practical skills to enhance its performance are important,
not only for managers in leadership positions but for all health workers.
Supply chain management activities are fundamental to any health programme's performance and all personnel involved,
whether it's an inventory manager in a warehouse, a doctor in a health facility or a procurement officer at the central medical store,
must have a good understanding of the basic principles of managing health commodities.
This course is designed to introduce you to the basic concepts of supply chain management
with specific focus on pharmaceuticals and health commodities in a developing country context.
Whilst covering a broad range of topics, the course delivery will emphasize the importance of integrating supply chain activities for overall health system strengthening.
After having successfully completed the module, students will be able to:
Define the essential medicines concept and rational use of medicines.
Describe the different steps and processes in the supply chain management of health commodities.
Interpret and discuss the roles of managers and different stakeholders in supply chain management, within the overall health system.
Be familiar with underlying principles of good storage and distribution practices of medicines.
Underline the key issues surrounding monitoring and evaluation of supply chain management.
Appreciate the importance and need for quality assurance of medicines along the supply chain.
Understand and critically analyse supply chain systems in different countries to identify practical approaches and intervention strategies.
- Good Manufacturing Practices and GMP Inspections for Medicines and Healthcare Products
1 June- 13 July, 450 euros, http://www.iplusacademy.org/enrol/iplus/cmp.php?courseid=68
The lack of a qualified human resources base in the manufacturing sector of medicines and other healthcare productst is a big challenge, especially in low and middle income countries.
In particular, there is need for skilled personnel for quality units (quality assurance, quality control) and other GMP relevant areas.
Costs for bringing in experts from abroad are high.
Combined with other challenges, local manufacturers often struggle to compete and even survive.
Not being in line with international quality standards, they are prevented from passing WHO prequalification, participating in international tenders, and entering international markets.
Moreover, the national medicines regulatory agencies (NMRAs) of these countries experience a shortage too of qualified staff in GMP, GMP inspection and dossier evaluation. This creates difficulties for the NMRAs to enforce internationally acceptable regulatory requirements (including GMP standards) thereby preventing the availability of affordable quality generics for the majority of their low income population groups.
This e-learning course introduces Good Manufacturing Practices and GMP inspections for medicines and healthcare products, focusing on WHO GMP standards and requirements as one of the major GMPs. Course participants will develop an understanding of the importance of implementing GMP in their daily working routine, starting from personnel hygiene to quality documentation and many other GMP requirements.
While the main focus in on medicines, an extra session of the course introduces the requirements for healthcare products, specifically female condoms. In the end, these capacity building measures in the area of GMP and GMP inspection will make the local manufacturing sector and the national regulatory authorities better equipped for production and regulation of quality assured essential medicines and healthcare products, in line with national and international standards.
After having successfully completed the course, participants will be able to:
Appreciate the importance and need for good manufacturing practices.
Be familiar with the development of medicines regulation.
Understand the main requirements in GMP, including procedural, organizational and infrastructural aspects.
Have gained basic information on requirements for healthcare products such as female condoms, as a special focus.
Critically analyse and implement basic GMP requirements in their daily working routine in the manufacturing and regulatory environment.
Understand the need for, and the benefit of GMP inspections.
Be familiar with different types of GMP inspections.
Interpret and discuss the role of GMP inspectors.
Understand the inspection process and structure of an inspection report.
Carole Piriou
Senior training coordinator
i+solutions
Universal Access to Essential Medicines
phone: +31 0348 748 722
address: Polanerbaan 11, 3447 GN, Woerden, The Netherlands
email: cpiriou@iplussolutions.org
website: www.iplusacademy.org
Carole Piriou <CPiriou@iplussolutions.org
Please find detailed course programmes and registration instructions on
www.iplusacademy.org .
- Quality Assurance in Supply Chain Management of Medicines
1 June- 29 June, 450 euros,
http://www.iplusacademy.org/enrol/iplus/cmp.php?courseid=66
Ensuring the quality of medicines is a major public health concern.
The emergence of substandard and counterfeit medicines, coupled with inefficient supply chain systems, not only poses a risk of negative health outcomes but also leads to economic losses and lack of trust in the health system.
To address these issues and develop evidence-based strategies,
it is important that people at all levels, from policy makers to primary healthcare workers appreciate
and comprehend the need for effective QA systems.
This course will introduce you to the concepts and main principles of quality assurance,
and will develop further skills and knowledge in different aspects of quality assurance
such as pharmaceutical regulation, pharmacovigilance and quality control of medicines.
After having successfully completed the module, students will be able to:
Define the key concepts and principles of quality assurance.
Comprehend the importance of quality assurance systems for medicines.
Describe how different functions of supply chain management affect the quality of medicines.
Explain the significance of shelf life and differentiate between types of stability studies.
Underline the key issues and challenges surrounding quality assurance systems especially in low and middle income countries.
- Basic principles of SCM in for health systems ( MBA level)
15 June-27 July, 450 euros,
http://www.iplusacademy.org/course/view.php?id=69
Many of the issues of healthcare quality and safety are consequences of poor management of pharmaceuticals.
Globally it is estimated that an average 25% of the total health expenditure is on medicines,
with poorer countries spending as much as 30%.
Knowledge of the full supply chain cycle of pharmaceuticals and practical skills to enhance its performance are important,
not only for managers in leadership positions but for all health workers.
Supply chain management activities are fundamental to any health programme's performance and all personnel involved,
whether it's an inventory manager in a warehouse, a doctor in a health facility or a procurement officer at the central medical store,
must have a good understanding of the basic principles of managing health commodities.
This course is designed to introduce you to the basic concepts of supply chain management
with specific focus on pharmaceuticals and health commodities in a developing country context.
Whilst covering a broad range of topics, the course delivery will emphasize the importance of integrating supply chain activities for overall health system strengthening.
After having successfully completed the module, students will be able to:
Define the essential medicines concept and rational use of medicines.
Describe the different steps and processes in the supply chain management of health commodities.
Interpret and discuss the roles of managers and different stakeholders in supply chain management, within the overall health system.
Be familiar with underlying principles of good storage and distribution practices of medicines.
Underline the key issues surrounding monitoring and evaluation of supply chain management.
Appreciate the importance and need for quality assurance of medicines along the supply chain.
Understand and critically analyse supply chain systems in different countries to identify practical approaches and intervention strategies.
- Good Manufacturing Practices and GMP Inspections for Medicines and Healthcare Products
1 June- 13 July, 450 euros, http://www.iplusacademy.org/enrol/iplus/cmp.php?courseid=68
The lack of a qualified human resources base in the manufacturing sector of medicines and other healthcare productst is a big challenge, especially in low and middle income countries.
In particular, there is need for skilled personnel for quality units (quality assurance, quality control) and other GMP relevant areas.
Costs for bringing in experts from abroad are high.
Combined with other challenges, local manufacturers often struggle to compete and even survive.
Not being in line with international quality standards, they are prevented from passing WHO prequalification, participating in international tenders, and entering international markets.
Moreover, the national medicines regulatory agencies (NMRAs) of these countries experience a shortage too of qualified staff in GMP, GMP inspection and dossier evaluation. This creates difficulties for the NMRAs to enforce internationally acceptable regulatory requirements (including GMP standards) thereby preventing the availability of affordable quality generics for the majority of their low income population groups.
This e-learning course introduces Good Manufacturing Practices and GMP inspections for medicines and healthcare products, focusing on WHO GMP standards and requirements as one of the major GMPs. Course participants will develop an understanding of the importance of implementing GMP in their daily working routine, starting from personnel hygiene to quality documentation and many other GMP requirements.
While the main focus in on medicines, an extra session of the course introduces the requirements for healthcare products, specifically female condoms. In the end, these capacity building measures in the area of GMP and GMP inspection will make the local manufacturing sector and the national regulatory authorities better equipped for production and regulation of quality assured essential medicines and healthcare products, in line with national and international standards.
After having successfully completed the course, participants will be able to:
Appreciate the importance and need for good manufacturing practices.
Be familiar with the development of medicines regulation.
Understand the main requirements in GMP, including procedural, organizational and infrastructural aspects.
Have gained basic information on requirements for healthcare products such as female condoms, as a special focus.
Critically analyse and implement basic GMP requirements in their daily working routine in the manufacturing and regulatory environment.
Understand the need for, and the benefit of GMP inspections.
Be familiar with different types of GMP inspections.
Interpret and discuss the role of GMP inspectors.
Understand the inspection process and structure of an inspection report.
Carole Piriou
Senior training coordinator
i+solutions
Universal Access to Essential Medicines
phone: +31 0348 748 722
address: Polanerbaan 11, 3447 GN, Woerden, The Netherlands
email: cpiriou@iplussolutions.org
website: www.iplusacademy.org
Carole Piriou <CPiriou@iplussolutions.org
Saturday, 9 May 2015
Beware of Dietary weight loss products - Warns NABP
Food and Drug Administration (FDA) has posted warnings regarding four products marketed as dietary supplements for weight loss that contain hidden drug ingredients. Three of the recalled products, “Slim Forte,” “Li Da Dai Dai Hua Slimming Capsule, ” and “Superior,” contain sibutramine, a controlled substance that was removed from the market in October 2010 for patient safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. A fourth product, “Fatloss Slimming Beauty, ” contains sildenafil, the active ingredient in the FDA-approved prescription medication Viagra®. This undeclared ingredient may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Men with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
The products included in the warnings are sold via the Internet and some retail stores. FDA advises consumers to stop using these products and to properly dispose of them. FDA also advises consumers to use caution before purchasing any supplements marketed for sexual enhancement, weight loss, or body building. Consumers and health care providers are encouraged to report any adverse events or quality problems experienced with these products to FDA’s MedWatch Safety Information and Adverse Event Reporting Program.
Source: NABP Newsletter
The products included in the warnings are sold via the Internet and some retail stores. FDA advises consumers to stop using these products and to properly dispose of them. FDA also advises consumers to use caution before purchasing any supplements marketed for sexual enhancement, weight loss, or body building. Consumers and health care providers are encouraged to report any adverse events or quality problems experienced with these products to FDA’s MedWatch Safety Information and Adverse Event Reporting Program.
Source: NABP Newsletter
RESEARCH ASSISTANTS Urgently Needed - Ministry of Health & Social Welfare
Post Title: Research Assistant
Background
The Ministry of Health and Social
Welfare (MOHSW) and the Drug Control Commission in collaboration with, the Centers
for Disease Control and Prevention, Muhimbili National Hospital, Mwananyamala
Municipal Hospital and Temeke Municipal Hospital is implementing a program aimed
at increasing coverage of people who use drugs (PWUDs) into medically assisted
treatment (MAT) of opioid dependence with an ultimate goal of minimizing HIV infection
among PWUDs. The program intends to
achieve this goal through execution of innovative Key Population Implementation
Science (KPIS) on Optimized Methadone Delivery with Take away Doses of
Methadone.
The MOHSW is currently seeking research
assistants for a research study aimed at exploring barriers and facilitators of
enrolment and retention in methadone treatment in order to develop a take-away
methadone delivery model for clients attending methadone clinics in Dar es
Salaam.
Study Description:
This research study will use in-depth
interviews with methadone clinic providers, methadone clients (current and
former), community outreach workers, and family/friends of methadone clients.
The research will be conducted at three methadone clinics in Dar es Salaam:
Muhimbili National Hospital, Mwananyamala Regional Hospital and Temeke Regional
Hospital.
Duration: 3 months (June 2015 to August
2015).
Number of positions: 8
Duty Station: Dar es Salaam
Report to: Research Director.
Duties/Responsibilities:
Attend training on qualitative research
and research ethics.
Assist in the recruitment of study
participants through methadone clinics and community outreach workers
affiliated with the methadone clinics.
Conduct in-depth interviews with
participants, including audio record interview and take interview notes.
Write debriefing field notes after each
interview.
Attend weekly debriefing meetings with
study investigators.
Transcribe interviews word-for-word in
Swahili.
Translate Swahili interview transcripts
into English.
Assist in preliminary data analysis, as
needed.
Qualifications:
Excellent oral and written communication
skills.
Excellent listening skills.
Proficiency in Microsoft Office
applications, specifically Microsoft Word.
Fluency in English and Swahili.
Strong typing skills.
Experience with community outreach
and/or conducting in-depth interviews preferred.
Previous experience in transcription and
translation preferred.
Ability to complete tasks within
specified deadlines.
Ability and openness to quickly learn
new skills.
University degree in the social and/or
behavioral sciences or related field preferred.
Those with previous experience working
with people who use or previously used drugs are encouraged to apply.
Application Procedures:
Qualified candidates meeting the above requirements
should submit a motivation letter together with updated curriculum vitae.
The deadline for receipt of all applications
is 3:30pm on Monday, May 11, 2015. Applications can be delivered at the address
given below and/or sent by e-mail/postal mail:
Permanent Secretary
Ministry of Health and Social Welfare
6 Samora Machel Avenue
11478 Dar es Salaam
Tanzania
Phone: +255-22-2342000/5
Fax: +255-22-2137951
Ministry of Health and Social Welfare
6 Samora Machel Avenue
11478 Dar es Salaam
Tanzania
Phone: +255-22-2342000/5
Fax: +255-22-2137951
Website: www.moh.go.tz
E-mail: ayoub_magimba@yahoo.com,
amsami@yahoo.com
Friday, 8 May 2015
Trainings at USP Ghana- Centre for Pharmaceutical Advancement & Training (CePAT)
USP-Ghana, the Center for Pharmaceutical Advancement and Training (CePAT) is pleased to provide details below on upcoming trainings. CePAT provides a comprehensive platform of training, testing, and consulting services that support and strengthen pharmaceutical quality assurance systems in countries within Sub-Saharan Africa.
Trainings
Pharmaceutical Quality Control Techniques This comprehensive module combines theoretical lectures and hands-on laboratory training and exercises to educate participants on the scientific approach and basic quality control techniques used in analytical laboratories.
Upcoming Dates
- Session 1: November 2-13, 2015
- Session 2: May 2-13, 2016
Good Manufacturing Practices (GMP)
This training module is designed to help participants gain an understanding of the fundamentals of medicines regulation and GMP for pharmaceutical products.
Upcoming Dates
- Session 1: July 6-17, 2015
- Session 2: January 4-15, 2016
Dossier Assessment and Registration of Medicines Through this module, CePAT offers hands-on training and analysis of real dossiers to help build the necessary knowledge and skills in dossier assessment and registration of medicines.
Upcoming Dates
- Session 1: September 7-18, 2015
- Session 2: March 7-18, 2016
Field-based Counterfeit Detection Technologies This module identifies some of the most well-known counterfeit medicine detection technologies and trains participants on the use of these technologies [Trainings are provided by request].
ISO Accreditation and WHO Prequalification As well as identifying and discussing the steps and work associated with obtaining accreditation or prequalification, this module provides information on how to identify accredited ISO providers, ISO/IEC calibration organizations, and accrediting bodies recognized by the International Laboratory Accreditation Cooperation [Trainings are provided by request].
Preventive Maintenance and Qualification of Laboratory Equipment This module teaches Official Medicines Control Laboratories staff how to perform basic servicing and qualification of laboratory equipment, reducing reliance on external providers [Trainings are provided by request].
Testing
CePAT's ISO 17025 accredited quality control laboratory can conduct physicochemical testing for monographs, testing of medicines for donor agencies, procurement organizations, and medicines regulatory authorities.
Consulting
We offer expert advice in laboratory operations, medicines regulation, supply chain integrity, and design of quality control laboratories to comply with ISO 17025 requirements.
Who We are
The U.S. Pharmacopeial Convention (USP) is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. Our mission is to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.
Many countries in Africa face a wide-ranging burden of disease that takes an enormous toll on social and economic development, and shortens life expectancy. To perpetuate U.S. Pharmacopeial Convention's core mission to improve global health, the Center for Pharmaceutical Advancement and Training (CePAT) was launched in May, 2013 in Accra, Ghana. To date, over 100 local industry professionals from 21 African nations have benefited from CePAT facilitated trainings focused on GMP, dossier evaluation and quality assurance, and now serve as technical experts in their respective fields.
Who We Serve
Staff of national regulatory authorities, quality and medicine control laboratories, pharmaceutical companies, manufacturers, and other allied chemical industries; as well as procurement agencies involved in product quality assessment; medical representatives involved in product dossier evaluation; and pharmacy students.
For further information please visit
http://www.usp.org/global-health-programs/center-pharmaceutical-advancement-and-training-cepat
or contact
CePAT@USP.org or Kwasi Boateng kpb@usp.org
Trainings
Pharmaceutical Quality Control Techniques This comprehensive module combines theoretical lectures and hands-on laboratory training and exercises to educate participants on the scientific approach and basic quality control techniques used in analytical laboratories.
Upcoming Dates
- Session 1: November 2-13, 2015
- Session 2: May 2-13, 2016
Good Manufacturing Practices (GMP)
This training module is designed to help participants gain an understanding of the fundamentals of medicines regulation and GMP for pharmaceutical products.
Upcoming Dates
- Session 1: July 6-17, 2015
- Session 2: January 4-15, 2016
Dossier Assessment and Registration of Medicines Through this module, CePAT offers hands-on training and analysis of real dossiers to help build the necessary knowledge and skills in dossier assessment and registration of medicines.
Upcoming Dates
- Session 1: September 7-18, 2015
- Session 2: March 7-18, 2016
Field-based Counterfeit Detection Technologies This module identifies some of the most well-known counterfeit medicine detection technologies and trains participants on the use of these technologies [Trainings are provided by request].
ISO Accreditation and WHO Prequalification As well as identifying and discussing the steps and work associated with obtaining accreditation or prequalification, this module provides information on how to identify accredited ISO providers, ISO/IEC calibration organizations, and accrediting bodies recognized by the International Laboratory Accreditation Cooperation [Trainings are provided by request].
Preventive Maintenance and Qualification of Laboratory Equipment This module teaches Official Medicines Control Laboratories staff how to perform basic servicing and qualification of laboratory equipment, reducing reliance on external providers [Trainings are provided by request].
Testing
CePAT's ISO 17025 accredited quality control laboratory can conduct physicochemical testing for monographs, testing of medicines for donor agencies, procurement organizations, and medicines regulatory authorities.
Consulting
We offer expert advice in laboratory operations, medicines regulation, supply chain integrity, and design of quality control laboratories to comply with ISO 17025 requirements.
Who We are
The U.S. Pharmacopeial Convention (USP) is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. Our mission is to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.
Many countries in Africa face a wide-ranging burden of disease that takes an enormous toll on social and economic development, and shortens life expectancy. To perpetuate U.S. Pharmacopeial Convention's core mission to improve global health, the Center for Pharmaceutical Advancement and Training (CePAT) was launched in May, 2013 in Accra, Ghana. To date, over 100 local industry professionals from 21 African nations have benefited from CePAT facilitated trainings focused on GMP, dossier evaluation and quality assurance, and now serve as technical experts in their respective fields.
Who We Serve
Staff of national regulatory authorities, quality and medicine control laboratories, pharmaceutical companies, manufacturers, and other allied chemical industries; as well as procurement agencies involved in product quality assessment; medical representatives involved in product dossier evaluation; and pharmacy students.
For further information please visit
http://www.usp.org/global-health-programs/center-pharmaceutical-advancement-and-training-cepat
or contact
CePAT@USP.org or Kwasi Boateng kpb@usp.org
Subscribe to:
Posts (Atom)